1. Home
  2. BRBI vs ORGO Comparison

BRBI vs ORGO Comparison

Compare BRBI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRBI BR Partners S.A. ADSs

BRBI

BRBI BR Partners S.A. ADSs

HOLD

Current Price

$11.50

Market Cap

293.2M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.41

Market Cap

299.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRBI
ORGO
Founded
2009
1985
Country
Brazil
United States
Employees
188
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.2M
299.8M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BRBI
ORGO
Price
$11.50
$2.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
1.2K
705.2K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
5.03%
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
N/A
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.24
$26.27
P/E Ratio
$11.72
N/A
Revenue Growth
N/A
17.04
52 Week Low
$10.90
$2.04
52 Week High
$67.01
$7.08

Technical Indicators

Market Signals
Indicator
BRBI
ORGO
Relative Strength Index (RSI) 41.10 46.89
Support Level $10.90 $2.26
Resistance Level $15.06 $2.58
Average True Range (ATR) 0.21 0.12
MACD 0.02 0.00
Stochastic Oscillator 21.98 35.09

Price Performance

Historical Comparison
BRBI
ORGO

About BRBI BRBI BR Partners S.A. ADSs

BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered. However, the company divides it's operations into the following business lines: (1) investment banking and capital markets, (2) treasury sales & structuring, (3) investments and wealth management and (4) capital remuneration.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: